Question 1

Has Katharine Price, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $6,964,804 in general payments to Katharine Price, MD across 28 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Katharine Price, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Katharine Price, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Merck	12	$6,844,741
Pfizer	8	$55,416
Ascendis Pharma Endocrinology Inc	3	$43,130
E.r. Squibb & Sons, L.L.C.	4	$21,500
Regeneron Healthcare Solutions, Inc.	1	$17

Katharine Price, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Other medical oncology in Rochester